Medical News Today (MNT)High Cholesterol May Predict Future Heart Disease Risk, Even in Healthy Women

Brigham Women’s Hospital study tracked 27,748 healthy women for 30 years, finding elevated lipoprotein(a) above 30 mg/dL increases cardiovascular disease risk independent of lifestyle, critical for OBGYN patients since Lp(a) is genetically determined and unaffected by diet or exercise. Women with Lp(a) above 120 mg/dL faced 10% higher absolute CVD risk across three decades.

💡 CLINICAL CONSIDERATIONS

• Lp(a) screening identifies genetic CVD risk in reproductive-age women before pregnancy, when cardiovascular stress increases and prevention strategies have maximum long-term impact.
• One in four women globally may have elevated Lp(a), making this a common finding in routine OBGYN panels that requires coordinated cardiology management.
• Pregnancy planning requires CVD risk stratification since elevated Lp(a) compounds risks from gestational hypertension, preeclampsia, and postpartum cardiomyopathy.
• Standard lifestyle counseling proves insufficient for Lp(a) management, necessitating aggressive LDL reduction with statins post-pregnancy and PCSK9 inhibitors for extreme elevations.

🎯 PRACTICE APPLICATIONS

• Screen reproductive-age patients with family history of early heart disease for baseline Lp(a) before pregnancy when prevention strategies have greatest impact.
• Coordinate cardiology referral for patients with Lp(a) above 30 mg/dL to establish aggressive LDL management and long-term CVD prevention plan.
• Counsel patients that genetic Lp(a) elevation requires medical management beyond diet and exercise, particularly statin therapy when not contraindicated by pregnancy.
• Document Lp(a) levels in prenatal records to guide monitoring for hypertensive disorders and inform postpartum cardiovascular risk assessment.

More in Cardiovascular Risk